<html xmlns:mims="http://www.mims.com">

<head>
	<META http-equiv="Content-Type" content="text/html; charset=UTF-8">
	<link type="text/css" href="css/redmond/jquery-ui.css" rel="stylesheet">
	<link type="text/css" href="css/mims.css" rel="stylesheet">
	<script type="text/javascript" src="scripts/jjQuery JavaScript Library v2.1.3.js"></script>
	<script type="text/javascript" src="scripts/jquery-ui.min.js"></script>
	<script type="text/javascript" src="scripts/drugalert.js"></script>
	<style>
		div.drug-label {
			width: 90mm;
			height: 35mm;
			border: 1pt solid;
			border-radius: 5pt;
			padding: 5pt;
			margin-bottom: 5pt;
		}

		.drug-label h4 {
			font-size: 10pt;
			font-weight: bold;
			font-family: Arial;
			margin: 2pt;
		}

		.drug-label p {
			font-size: 8pt;
			font-weight: normal;
			font-family: Arial;
			margin: -1pt 2pt 2pt 2pt;
		}

		.cals-details p {
			margin-bottom: 0pt;
		}

		.cal-details li a {
			text-decoration: none;
		}

		.cal-details strong {
			margin-right: 2pt;
		}

		ol.allergy-list {
			padding-left: 1.33em;
		}

		ol.allergy-list>li {
			padding-top: 0.5em;
		}

		ol.allergy-list h4.subheading {
			margin-top: 0.2em;
		}
	</style>
</head>

<body>
	<div id="tabs" class="tab-container">
		<ul>
			<li><a href="#tab-interaction">Drug Interaction (2)</a></li>
			<li><a href="#tab-allergy">Allergy (3)</a></li>
			<li><a href="#tab-health">Health Conditions (3)</a></li>
		</ul>
		<div id="tab-interaction" class="acc_container">
			<div id="list_interactions">
				<div id="i_4_captopril_aspirin">
					<h3><a href="#">
							<table class="severity">
								<tr>
									<td class="severity4"></td>
								</tr>
							</table>&nbsp;
							captopril 100mg Oral Tablet (captopril/Systemic) vs acetylsalicylic acid 100mg Enteric
							Coated Tablet (aspirin/Systemic)
							[Use combination with caution.]
						</a></h3>
					<div>
						<h4 class="subheading">Interaction Effect</h4>
						<p>captopril has its effect reduced by aspirin</p>
						<h4 class="subheading">Severity Level</h4>
						<p><em>Moderate</em> -
							These medications may interact resulting in the potential deterioration of the patient's
							condition. The patient should be monitored for the possible manifestations of the
							interaction. Medical intervention or a change in therapy may be required.
						</p>
						<h4 class="subheading">Documentation Level</h4>
						<p><em>Good</em> -
							Although controlled studies may not have been performed, several case reports have been
							documented and other data strongly suggests this interaction exists.
						</p>
						<div id="r_i_4_captopril_aspirin" style="display: block">
							<h4 class="subheading">Probable Mechanism</h4>Salicylates may reduce the beneficial effects
							of angiotensin converting enzyme inhibitors (ACEIs). Salicylates inhibit synthesis of
							prostaglandins and may antagonise antihypertensive effects of ACEIs in a dose-dependent
							manner, cause vasoconstriction/reduced cardiac output in heart failure patients, as well as
							increased risk of renal impairment. However, studies have shown that low-dose aspirin (less
							than or equals to 100 mg per day) is less likely to interact with ACEI. Furthermore, there
							are conflicting results of aspirin&rsquo;s effect to worsen heart failure in patients on
							concomitant ACEI. Nevertheless, if concurrent use is necessary, monitor patient&rsquo;s
							clinical condition, blood pressure and renal function.<h4 class="subheading">Actions to be
								taken</h4>
							<ol>
								<li>Use combination with caution.</li>
								<li>Monitor patient clinically.</li>
								<li>Monitor renal function.</li>
								<li>Monitor blood pressure.</li>
							</ol>
							<h4 class="subheading">References</h4>
							<ul>
								<li>Meune C, Mourad JJ, Bergmann JF et al. Interaction between cyclooxygenase and the
									renin-angiotensin-aldosterone system: rationale and clinical relevance.
									<i>J Renin Angiotensin Aldosterone Syst</i>. 2003; 4(3/Sep):149-54</li>
								<li>Levy PD, Nandyal D, Welch RD et al. Does aspirin use adversely influence
									intermediate-term postdischarge outcomes for hospitalized patients who are treated
									with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?
									Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized
									Patients with Heart Failure (OPTIMIZE-HF). <i>Am Heart J</i>. 2010;
									159(2/Feb):222-230</li>
								<li>Stys T, Lawson WE, Smaldone GC et al. Does aspirin attenuate the beneficial effects
									of angiotensin-converting enzyme inhibition in heart failure?.
									<i>Arch Intern Med</i>. 2000; 160(10/May 22):1409-13</li>
								<li>Guazzi M, Brambilla R, Reina G et al. Aspirin-angiotensin-converting enzyme
									inhibitor coadministration and mortality in patients with heart failure: a
									dose-related adverse effect of aspirin. <i>Arch Intern Med</i>. 2003; 163(13/Jul
									14):1574-9</li>
								<li>Meune C, Mahe I, Mourad JJ et al. Interaction between angiotensin-converting enzyme
									inhibitors and aspirin: a review. <i>Eur J Clin Pharmacol</i>. 2000;
									56(9-10/Dec):609-20</li>
								<li>Masoudi FA, Wolfe P, Havranek EP et al. Aspirin use in older patients with heart
									failure and coronary artery disease: national prescription patterns and relationship
									with outcomes. <i>J Am Coll Cardiol</i>. 2005; 46(6/Sep 20):955-62</li>
								<li>ACE inhibitors + Aspirin. Stockleys Drug Interactions. MedicinesComplete. Baxter K
									(ed). RPS Publishing. London. UK. Available from URL: <a
										href="http://www.medicinescomplete.com/mc">http://www.medicinescomplete.com/mc</a>.
									(Accessed on 19/09/2016)</li>
							</ul>
						</div>
					</div>
				</div>
				<div id="i_4_captopril_trimethoprim">
					<h3><a href="#">
							<table class="severity">
								<tr>
									<td class="severity4"></td>
								</tr>
							</table>&nbsp;
							captopril 100mg Oral Tablet (captopril/Systemic) vs trimethoprim 300mg Oral Tablet
							(trimethoprim/Systemic)
							[Use combination with extreme caution.]
						</a></h3>
					<div>
						<h4 class="subheading">Interaction Effect</h4>
						<p>captopril causes additive toxicity with trimethoprim</p>
						<h4 class="subheading">Severity Level</h4>
						<p><em>Moderate</em> -
							These medications may interact resulting in the potential deterioration of the patient's
							condition. The patient should be monitored for the possible manifestations of the
							interaction. Medical intervention or a change in therapy may be required.
						</p>
						<h4 class="subheading">Documentation Level</h4>
						<p><em>Good</em> -
							Although controlled studies may not have been performed, several case reports have been
							documented and other data strongly suggests this interaction exists.
						</p>
						<div id="r_i_4_captopril_trimethoprim" style="display: block">
							<h4 class="subheading">Probable Mechanism</h4>The concurrent use of ACE inhibitors and
							trimethoprim may lead to additive risk of hyperkalaemia by inhibiting the renal excretion of
							potassium. Meta-analyses in geriatric population found that coadministration of
							co-trimoxazole and an ACE inhibitor has been associated with higher risk of hospitalisation
							due to hyperkalaemia or sudden death. Moreover, various reports of severe hyperkalaemia and
							arrhythmias have been described when trimethoprim or co-trimoxazole was given concomitantly
							with an ACE inhibitor. Other predisposing factors include renal impairment, elderly, high
							dosages and diabetes. Closely monitor at-risk patient&rsquo;s serum potassium levels and ECG
							during combined use. Consider adjusting dose or use an alternative antibiotic in elderly
							patients.<h4 class="subheading">Actions to be taken</h4>
							<ol>
								<li>Use combination with extreme caution.</li>
								<li>Monitor serum potassium.</li>
							</ol>
							<h4 class="subheading">References</h4>
							<ul>
								<li>Cohen MR, Smetzer JL. ISMP Medication Error Report Analysis: Safe Practice
									Environment Chapter Proposed by United States Pharmacopeia:
									Sulfamethoxazole/Trimethoprim and Lisinopril Hyperkalemia. <i>Hosp Pharm</i>. 2009;
									44(3/Mar):210-3</li>
								<li>Bugge JF. Severe hyperkalaemia induced by trimethoprim in combination with an
									angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
									<i>J Intern Med</i>. 1996; 240(4/Oct):249-51</li>
								<li>Fralick M, Macdonald EM, Gomes T et al. Co-trimoxazole and sudden death in patients
									receiving inhibitors of renin-angiotensin system: population based study.
									<i>BMJ</i>. 2014; 349(Oct 30):g6196</li>
								<li>Antoniou T, Gomes T, Juurlink DN et al. Trimethoprim-sulfamethoxazole-induced
									hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a
									population-based study. <i>Arch Intern Med</i>. 2010; 170(12/Jun 28):1045-9</li>
								<li>Patel MC. Trimethoprim related Hyperkalaemia in a patient with Renal Tubular
									Acidosis Type 4. <i>Acute Med</i>. 2009; 8(3):117-8</li>
								<li>ACE inhibitors/Trimethoprim. Drug Interaction Facts. Facts and Comparisons eAnswers.
									Tatro DS. Wolters Kluwer Health, Inc. St. Louis, MI. USA. Available from URL: <a
										href="http://online.factsandcomparisons.com">http://online.factsandcomparisons.com</a>.
									(Accessed on 21/01/2015)</li>
							</ul>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div id="tab-health" class="acc_container">
			<div id="list_health">
				<div id="i_2_aspirin_j45">
					<h3><a href="#">
							<table class="severity">
								<tr>
									<td class="severity3"></td>
								</tr>
							</table>&nbsp;
							acetylsalicylic acid 100mg Enteric Coated Tablet (aspirin)
							vs J45 (Asthma)
						</a></h3>
					<div>
						<h4 class="subheading">Severity Level</h4>
						<p><em>Extreme Caution</em> -
							Use of the drug is not recommended and the patient has a higher risk of developing adverse
							effects or exacerbation of their existing health condition, however, use is still possible
							and the risk may be outweighed by other considerations.</p>
						<h4 class="subheading">Documentation Level</h4>
						<p><em>Limited</em> -
							Few reports of this interaction exist. These few reports usually consist of limited case
							reports where clinically sound justification of the interaction is found.
						</p>
						<div id="r_i_2_aspirin_j45" style="display: block">
							<h4 class="subheading">Probable Mechanism</h4>Salicylates may precipitate or exacerbate
							asthma, and risk increases in asthmatic patients with chronic rhinitis or a history of nasal
							polyps. Contraindicated in severe asthma.<h4 class="subheading">References</h4>
							<ul>
								<li>Kacso G, Terezhalmy GT. Acetylasalicylic acid and acetaminophen.
									<i>Dent Clin North Am</i>. 1994; 38(4/Oct):633-44</li>
								<li>Barranco P, Bobolea I, Larco JI et al. Diagnosis of aspirin-induced asthma combining
									the bronchial and the oral challenge tests: a pilot study.
									<i>J Investig Allergol Clin Immunol</i>. 2009; 19(6):446-52</li>
								<li>Mascia K, Haselkorn T, Deniz YM et al. Aspirin sensitivity and severity of asthma:
									evidence for irreversible airway obstruction in patients with severe or
									difficult-to-treat asthma. <i>J Allergy Clin Immunol</i>. 2005; 116(5/Nov):970-5
								</li>
							</ul>
						</div>
					</div>
				</div>
				<div id="i_3_aspirin_n17">
					<h3><a href="#">
							<table class="severity">
								<tr>
									<td class="severity5"></td>
								</tr>
							</table>&nbsp;
							acetylsalicylic acid 100mg Enteric Coated Tablet (aspirin)
							vs N17 (Acute renal failure)
						</a></h3>
					<div>
						<h4 class="subheading">Severity Level</h4>
						<p><em>Contraindicated</em> -
							Absolute contraindication; the use of the drug is completely inadvisable and should be
							avoided.</p>
						<h4 class="subheading">Documentation Level</h4>
						<p><em>Good</em> -
							Although controlled studies may not have been performed, several case reports have been
							documented and other data strongly suggests this interaction exists.
						</p>
						<div id="r_i_3_aspirin_n17" style="display: block">
							<h4 class="subheading">Probable Mechanism</h4>Salicylates are associated with renal toxicity
							(e.g. nephropathy) and aspirin has been shown to prolong bleeding time in some patients with
							uraemia. Contraindicated in severe renal impairment.<h4 class="subheading">References</h4>
							<ul>
								<li>Ibanez L, Morlans M, Vidal X et al. Case-control study of regular analgesic and
									nonsteroidal anti-inflammatory use and end-stage renal disease. <i>Kidney Int</i>.
									2005; 67(6/Jun):2392-8</li>
								<li>Gaspari F, Vigano G, Orisio S et al. Aspirin prolongs bleeding time in uremia by a
									mechanism distinct from platelet cyclooxygenase inhibition. <i>J Clin Invest</i>.
									1987; 79(6/Jun):1788-97</li>
								<li>Abraham PA, Stillman MT. Salsalate exacerbation of chronic renal insufficiency.
									Relation to inhibition of prostaglandin synthesis. <i>Arch Intern Med</i>. 1987;
									147(9/Sep):1674-6</li>
								<li>Salicylates general statement. American Hospital Formulary Service Drug Information.
									MedicinesComplete. McEvoy GK (ed). RPS Publishing. London. UK. Available from URL:
									<a
										href="http://www.medicinescomplete.com/mc">http://www.medicinescomplete.com/mc</a>.
									(Accessed on 18/02/2009)</li>
							</ul>
						</div>
					</div>
				</div>
				<div id="i_2_trimethoprim_n17">
					<h3><a href="#">
							<table class="severity">
								<tr>
									<td class="severity3"></td>
								</tr>
							</table>&nbsp;
							trimethoprim 300mg Oral Tablet (trimethoprim)
							vs N17 (Acute renal failure)
						</a></h3>
					<div>
						<h4 class="subheading">Severity Level</h4>
						<p><em>Extreme Caution</em> -
							Use of the drug is not recommended and the patient has a higher risk of developing adverse
							effects or exacerbation of their existing health condition, however, use is still possible
							and the risk may be outweighed by other considerations.</p>
						<h4 class="subheading">Documentation Level</h4>
						<p><em>Good</em> -
							Although controlled studies may not have been performed, several case reports have been
							documented and other data strongly suggests this interaction exists.
						</p>
						<div id="r_i_2_trimethoprim_n17" style="display: block">
							<h4 class="subheading">Probable Mechanism</h4>Trimethoprim has been reported to cause
							hyperkalaemia by reducing renal tubular secretion of potassium. Monitor serum potassium
							closely in patients with severe renal impairment. Use with extreme caution in patients with
							severe renal impairment.<h4 class="subheading">References</h4>
							<ul>
								<li>Zietse R, Zoutendijk R, Hoorn EJ. Fluid, electrolyte and acid-base disorders
									associated with antibiotic therapy. <i>Nat Rev Nephrol</i>. 2009; 5(4/Apr):193-202
								</li>
								<li>Perazella MA. Trimethoprim-induced hyperkalaemia: clinical data, mechanism,
									prevention and management. <i>Drug Saf</i>. 2000; 22(3/Mar):227-36</li>
								<li>Alappan R, Perazella MA, Buller GK. Hyperkalemia in hospitalized patients treated
									with trimethoprim-sulfamethoxazole. <i>Ann Intern Med</i>. 1996; 124(3/Feb 1):316-20
								</li>
								<li>Margassery S, Bastani B. Life threatening hyperkalemia and acidosis secondary to
									trimethoprim-sulfamethoxazole treatment. <i>J Nephrol</i>. 2001; 14(5/Sep-Oct):410-4
								</li>
								<li>Trimethoprim. Martindale: The Complete Drug Reference. MedicinesComplete. Sweetman S
									(ed). RPS Publishing. London. UK. Available from URL: <a
										href="http://www.medicinescomplete.com/mc">http://www.medicinescomplete.com/mc</a>.
									(Accessed on 01/12/2016)</li>
								<li>Trimethoprim Oral - Renal Disease Precaution. Drug Interaction Facts. Facts and
									Comparisons eAnswers. Tatro DS. Wolters Kluwer Health, Inc. St. Louis, MI. USA.
									Available from URL: <a
										href="http://online.factsandcomparisons.com">http://online.factsandcomparisons.com</a>.
									(Accessed on 15/12/2016)</li>
							</ul>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div id="tab-allergy" class="acc_container">
			<div id="list_allergies">
				<div id="a_amoxicillin_trihydrate_250mg_oral_capsule">
					<h3><a href="#">Patient may be allergic to the prescribing item, amoxicillin trihydrate 250mg Oral
							Capsule.</a></h3>
					<div>
						<div>
							<h4 class="subheading">Allergy history:</h4>
							<ol class="allergy-list">
								<li>The patient has a known history of allergic reaction to SubstanceClass,
									<em>Penicillins</em>.<ul class="no-bullet-no-indent">
										<li><em>amoxicillin trihydrate 250mg Oral Capsule</em> contains
											<em>amoxicillin trihydrate</em>, which belongs to that same substance
											class.<em>Penicillins</em>.</li>
									</ul>
								</li>
							</ol>
						</div>
					</div>
				</div>
				<div id="a_acetylsalicylic_acid_100mg_enteric_coated_tablet">
					<h3><a href="#">Patient may be allergic to the prescribing item, acetylsalicylic acid 100mg Enteric
							Coated Tablet.</a></h3>
					<div>
						<div>
							<h4 class="subheading">Allergy history:</h4>
							<ol class="allergy-list">
								<li>The patient has a known history of allergic reaction to SubstanceClass,
									<em>Salicylates</em>.<ul class="no-bullet-no-indent">
										<li><em>acetylsalicylic acid 100mg Enteric Coated Tablet</em> contains
											<em>aspirin</em>, which belongs to that same substance
											class.<em>Salicylates</em>.</li>
									</ul>
								</li>
							</ol>
						</div>
					</div>
				</div>
				<div id="a_trimethoprim_300mg_oral_tablet">
					<h3><a href="#">Patient may be allergic to the prescribing item, trimethoprim 300mg Oral Tablet.</a>
					</h3>
					<div>
						<div>
							<h4 class="subheading">Allergy history:</h4>
							<ol class="allergy-list">
								<li>The patient has a known history of allergic reaction to Molecule,
									<em>trimethoprim</em>.<ul class="no-bullet-no-indent">
										<li><em>trimethoprim 300mg Oral Tablet</em> contains <em>trimethoprim</em>.
										</li>
									</ul>
								</li>
							</ol>
						</div>
					</div>
				</div>
			</div>
		</div>
	</div>
</body>

</html>